Sequana Medical - alfapump system

Startpagina
België
Sint-Denijs-Westrem
Sequana Medical - alfapump system

Over 900 alfapump® systems have been implanted.

The alfapump®, is a fully implantable, programmable, wirelessly-charged, battery-powered system that is CE-marked for the treatment of refractory ascites due to liver cirrhosis and malignant ascites. The alfapump® has been endorsed by key independent third parties in Europe and has received Breakthrough Device status from the US FDA. We have leveraged our alfapump® technology experience and are de

veloping alfapump DSR®, a novel and proprietary approach to the treatment of fluid overload in patients suffering from heart failure.

21/05/2026

For patients living with recurrent or refractory ascites due to liver cirrhosis, the impact on daily life can be significant. Hear from Ron about his experience with the alfapump System and how it changed his life, from eating and sleeping well again, to returning to work and getting back to normal physical activity.

Patient testimonial represents one individual’s experience. Individual results may vary.

IMPORTANT SAFETY INFORMATION: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination. Important risks include: peritoneal cavity infections, pump pocket complications, catheter-related issues, and genito-urinary complications. The system is MRI unsafe.

For full important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

19/05/2026

The pivotal POSEIDON study, published in the American Journal of Gastroenterology, assessed the safety and efficacy of the alfapump System in patients with recurrent or refractory ascites due to liver cirrhosis.

The study found that implantation significantly reduced the need for therapeutic paracentesis, with the majority of patients achieving a meaningful reduction in drainage procedures. Patients also reported significant improvements in quality of life, including an average of 10 additional good health days per month.

Read the full publication: https://journals.lww.com/ajg/fulltext/2025/10000/the_effects_of_alfapump_on_ascites_control_and.21.aspx

For important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

04/05/2026

May is Hepatitis Awareness Month, a timely reminder that viral hepatitis, if left untreated, can lead to cirrhosis, liver failure, and liver cancer. Millions of people are living with chronic hepatitis B or C without knowing it, and for those who do develop advanced liver disease, the consequences can be life-altering.

At Sequana Medical, we work every day for patients navigating the serious complications of advanced liver disease, including those living with recurrent or refractory ascites due to liver cirrhosis.

This month, we stand with the hepatitis awareness community in encouraging adults to get tested and vaccinated.

https://www.cdc.gov/hepatitis-awareness/about/index.html

24/04/2026

The alfapump System is the first and only FDA-approved active implantable medical device for the treatment of recurrent or refractory ascites due to liver cirrhosis.

Here’s how it works:

The pump is implanted under the skin in an approximately 80-minute procedure performed by an interventional radiologist. Once in place, it automatically and continuously moves fluid from the abdomen to the bladder, where it is naturally eliminated. No needles. No external tubes. No repeated hospital visits for drainage.

The only daily requirement for patients is a simple 20-minute wireless recharge, similar to charging a phone. During that time, pump performance data is collected and this enables the Sequana team to send regular reports to the treating physician, providing important insights on the patient’s progress with the alfapump.

For patients who have lived around the schedule of paracentesis, that is a meaningful shift.

Learn more at https://www.sequanamedical.com/

For important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

20/04/2026

The physical demands and frequency of paracentesis procedures can significantly impact patients with ascites due to liver cirrhosis.

David describes his experience with traditional paracentesis treatments, including the physical discomfort and logistical challenges of frequent hospital visits, before receiving the alfapump® System, an FDA-approved treatment for adults with refractory or recurrent ascites due to liver cirrhosis.

Excerpt from full patient story. Full video available at https://www.youtube.com/watch?v=zDkztv5wmpo

Patient testimonial represents one individual’s experience. Individual results may vary.

IMPORTANT SAFETY INFORMATION: The alfapump® System is intended for single patient use only in adult patients with refractory or recurrent ascites due to liver cirrhosis. It is indicated for the removal of excess peritoneal fluid from the peritoneal cavity into the bladder, where it can be eliminated through normal urination.

Important risks include: peritoneal cavity infections, pump pocket complications, catheter-related issues, and genito-urinary complications. The system is MRI unsafe.

For full important safety information, visit:https://www.sequanamedical.com/wp-content/uploads/ISI.pdf

19/04/2026

Today is World Liver Day 🌍

This year’s theme, “Solid Habits, Strong Liver,” is a powerful reminder of how much lifestyle choices impact liver health and why early intervention matters. Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one-third of the global population, but small, steady changes to diet, exercise and drinking habits and regular check-ups can prevent serious complications, like liver scarring, cirrhosis or even liver cancer.

For the 1.5 billion people already living with chronic liver disease worldwide, the stakes are high. At Sequana Medical, we’re focused on those navigating the serious consequences of advanced liver disease, including patients with recurrent or refractory ascites due to liver cirrhosis.

On this World Liver Day, we stand with the global liver disease community in the effort to raise awareness of liver health and improve outcomes and quality of life for patients everywhere.

🔗 worldliverday.org

$For patients living with recurrent or refractory liver ascites due to cirrhosis, daily life can be incredibly difficult ...$

09/04/2026

For patients living with recurrent or refractory liver ascites due to cirrhosis, daily life can be incredibly difficult

Up to 10-15 liters of fluid can accumulate in the abdomen every 15 days, placing pressure on surrounding organs. Fatigue, shortness of breath, difficulty eating and sleeping, and withdrawal from everyday life are all part of the reality these patients face.

https://www.sequanamedical.com/alfapump/liver-disease-ascites/

$For decades, the standard of care for patients living with recurrent or refractory ascites due to liver cirrhosis, has m...$

07/04/2026

For decades, the standard of care for patients living with recurrent or refractory ascites due to liver cirrhosis, has meant a never-ending cycle of burdensome and invasive paracentesis procedures.

This World Health Day, we’re proud to and drive the effort to transform the lives of patients by delivering innovation that aims to change the standard of care for patients living with this challenging condition.

21/12/2023

🎄✨ Season's Greetings from Sequana Medical

As the year draws to a close, we at Sequana want to extend our warmest wishes to each and every one of our followers, clients, and partners. 🌟

🎅 Merry Christmas 🎅 and a 🎉 Happy New Year 🎉 to you and your loved ones!

The festive season is a time of reflection, gratitude, and hope. We reflect on the challenges we have overcome, the successes we have celebrated, and the lessons we have learned. Looking ahead, we are filled with optimism and excitement for what 2024 holds.

Thank you for being part of the Sequana family. 👍 Stay connected with us for exciting updates and opportunities in 2024.

05/10/2023

“🇩🇪 Happy German National Day! 🇩🇪

On this special day, we commemorate the reunification of Germany and celebrate the rich history, culture, and achievements of this incredible nation.

Germany has long been a global powerhouse in fields such as engineering, technology, arts, and innovation. Its commitment to excellence and continuous progress is an inspiration to us all.

Whether you're enjoying a traditional German meal, raising a glass of beer, or simply taking a moment to appreciate all that Germany has contributed to the world, let's join in spirit to honor this remarkable nation.

Wishing everyone in Germany and around the world a joyful and memorable German National Day! 🎉🎈

02/10/2023

🚀 Just a Few Days Away! AFEF Congress in Rennes - Oct 4-6 📆

The countdown is on! In just a few days, we'll be gathering in Rennes for the highly anticipated AFEF Congress, taking place from October 4th to October 6th.

🌟 Here's what you can expect:
✅ Deep insights into Therapy
✅ Engaging discussions with our experts
✅ Cutting-edge healthcare innovations

We're particularly excited to invite you to join us at Booth No. 4 for in-depth discussions about alfapump Therapy.
Whether you're a seasoned professional or just getting started in the field, this congress is a must-attend.

We are looking forward to connect, collaborate, and learn with you at the AFEF Congress in beautiful Rennes.

See you there!

Adres

Kortrijksesteenweg 1112 Bus 102
Sint-Denijs-Westrem
9051

Website

http://www.alfapump.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Sequana Medical - alfapump system nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.